Concerning Western blot analysis, a reduced SESN2 level was also detected after siRNA transfection, and siRNA transfection prior to BA treatment prevented BA-mediated SESN2 induction in all three breast cancer cell lines (Figure 5D–F). This evidence concerns the gene SESN2 and breast cancer.